Drug solution injection device
The drug solution injector maintains higher pressure in the common conduit section using a control device to prevent backflow, addressing the hygiene and cost issues in existing devices by ensuring the flow cutoff unit operates based on pressure thresholds.
Patent Information
- Application Number
- JP2024147595
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2018-06-29
- Filing Date
- 2024-08-29
- Publication Date
- 2024-11-08
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The challenge in existing drug injection devices is the backflow of body fluids into the common conduit section due to the inability to maintain higher pressure on the upstream side of the chemical liquid supply path, which compromises the hygiene and cost-effectiveness of the system.
A drug solution injector with a control device that manages the flow cutoff unit to maintain higher pressure in the common conduit section than the intravascular pressure, using electrical or wireless connections to control the flow cutoff unit based on predetermined pressure thresholds, ensuring the flow is blocked when the pressure drops below the set threshold.
Prevents backflow of body fluids into the common conduit section, maintaining hygiene and extending the replacement cycle of the common conduit section, thereby enhancing the efficiency and cost-effectiveness of the drug injection process.
Smart Images

Figure 2024159936000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a liquid injector that closes a flow path for injecting a liquid into a subject. [Background technology]
[0002] Medical imaging diagnostic examination methods include a method using a computer tomography diagnostic apparatus (CT apparatus), a method using a nuclear magnetic resonance imaging apparatus (MRI apparatus), a method using an angiography imaging apparatus (angiography), and the like. In general, when using such an apparatus, two liquids, a contrast agent and a physiological saline solution (hereinafter referred to as "medicinal liquids"), are injected into a subject such as a patient in a predetermined process. The medical liquid injection apparatus of the present invention is an apparatus for injecting a medical liquid into a subject in such an imaging diagnostic apparatus.
[0003] The contrast medium is injected into the subject from a syringe attached to a liquid injector, as in the device disclosed in Patent Document 1. Patent Document 1 discloses that liquids are injected into the subject from two syringes, one for the contrast medium and one for physiological saline, by switching between them at a predetermined timing.
[0004] Patent Document 2 discloses a clamping mechanism that crushes a flexible tube to block a predetermined portion of a flow path that supplies a liquid medicine. This clamping mechanism crushes the flexible tube with a clamp member so that a predetermined liquid medicine can be injected in a predetermined procedure.
[0005] The drug solution injection pipeline in such a drug solution injector has a replacement pipeline section that is replaced for each subject for hygienic reasons, and a common pipeline section that is used commonly by multiple subjects for cost reasons. The replacement pipeline section and the common pipeline section can be detachably connected at a joint at a predetermined location. The former is a pipeline consisting of a puncture member such as a needle or catheter that is introduced into the subject's blood vessel and a tube connected to the puncture member and placed on the subject side, and is a pipeline that needs to be replaced in short cycles for each subject for hygienic reasons. On the other hand, the latter is a pipeline consisting of a tube placed on the side of a high-precision device such as a drug solution injector including a syringe and a drug solution source, and is a pipeline that is suitable for replacement in long cycles from the viewpoint of cost.
[0006] In the drug injection pipeline, there is a possibility that the subject's body fluid, such as blood, downstream of the drug supply path may flow backward to the upstream of the drug injection pipeline. If the body fluid flows backward beyond the body fluid replacement pipeline of a given subject to the common pipeline, the injection of drug fluid for the next subject will require the replacement of the common pipeline as well, instead of only the replacement pipeline. In this case, the common pipeline will end up needing to be replaced in a short cycle, despite its long-cycle replacement, and the purpose of providing the common pipeline will be defeated. Therefore, it is necessary to prevent the subject's body fluid from flowing backward to the common pipeline by confining the backward flow to the replacement pipeline. [Prior art documents] [Patent documents]
[0007] [Patent Document 1] JP 2004-065736 A [Patent Document 2] International Publication No. 2014 / 104338 Summary of the Invention [Problem to be solved by the invention]
[0008] In general, incompressible fluids such as liquids flow from high pressure to low pressure, so backflow can be prevented by keeping the pressure on the upstream side of the pipeline higher than the downstream side. Therefore, in a liquid injection circuit, it is necessary to always keep the pressure on the upstream side of the liquid supply path higher than the pressure on the downstream side. [Means for solving the problem]
[0009] A drug solution injector for injecting a drug solution into a subject, the drug solution injector comprising a drug solution source having an opening and drug solution supply means for discharging the drug solution from the opening; a replacement pipe line section for supplying the drug solution to a blood vessel of the subject; a common pipe line section connected to the opening of the drug solution source and for allowing the drug solution to flow from the drug solution injector to the replacement pipe line section; a control device electrically connected to the drug solution supply means by wire or wirelessly and for controlling the operation of the drug solution supply means; and a control device disposed in a pipe within the replacement pipe line section or at a boundary between the replacement pipe line section and the common pipe line section and electrically connected to the control device by wire or wirelessly. This problem is solved by a drug solution injection device which includes a flow blocking unit, the drug solution supply means electrically connected by a wire being switchable between an open state which allows the flow of the drug solution and a closed state which blocks the flow of the drug solution upon receiving a command from the control device, and the control device sends a command to the flow blocking unit to switch the flow blocking unit to the open state which allows the flow of the drug solution when a first predetermined time has elapsed after the supply of the drug solution has started from the drug solution injector, and to the closed state which blocks the flow of the drug solution when a second predetermined time has elapsed after the supply of the drug solution from the drug solution injector has been completed.
[0010] A drug solution injector for injecting a drug solution into a subject, the drug solution injector comprising a drug solution source having an opening and drug solution supply means for discharging the drug solution from the opening, a replacement pipeline section for supplying the drug solution to a blood vessel of the subject, a common pipeline section connected to the opening of the drug solution source and for allowing the drug solution to flow from the drug solution injector to the replacement pipeline section, a control device electrically connected to the drug solution supply means by wire or wirelessly and for controlling the operation of the drug solution supply means, and a control device disposed in a pipeline within the replacement pipeline section or at a boundary between the replacement pipeline section and the common pipeline section, This problem is solved by a drug solution injection device that includes a flow blocking unit, the drug solution supplying means being electrically connected to the control device by wire or wirelessly and that can switch between an open state that allows the flow of the drug solution and a closed state that blocks the flow of the drug solution upon receiving a command from the control device, and the control device sends a command to the flow blocking unit to switch to the open state that allows the flow of the drug solution when the pressure in the common pipe section reaches a predetermined pressure higher than the intravascular pressure of the subject, and to the closed state that blocks the flow of the drug solution when the pressure in the common pipe section falls below the predetermined pressure. Effect of the Invention
[0011] This makes it possible to prevent backflow of the subject's body fluids through the replacement pipeline section into the common pipeline section in the drug solution injection pipeline. [Brief description of the drawings]
[0012] [Figure 1] 1 is a schematic diagram of a chemical liquid injector according to a first embodiment of the present invention; [Figure 2A] FIG. 2 is a diagram showing an example of a flow interruption unit of the present invention. [Figure 2B] FIG. 13 is a diagram showing another example of the flow interrupting unit of the present invention. [Figure 3A] 4 is a schematic diagram showing a history of pressure changes in a drug solution injection pipeline according to the present invention. FIG. [Figure 3B] FIG. 4 is a flowchart showing a liquid injection process of the liquid injection device of the present invention. [Figure 4]1 is a diagram showing an example of a method for measuring pressure in a drug solution injection pipeline according to the present invention. [Diagram 5] FIG. 11 is a schematic diagram of a chemical liquid injector according to a second embodiment of the present invention. [Figure 6] FIG. 11 is a schematic diagram of a chemical liquid injector according to a third embodiment of the present invention. [Figure 7A] FIG. 11 is a schematic diagram of an example of a pressurizing body of a chemical liquid injector according to a third embodiment of the present invention. [Figure 7B] FIG. 13 is a schematic view of another example of the pressurizing body of the chemical liquid injector according to the third embodiment of the present invention. [Figure 8] FIG. 13 is a schematic diagram of a chemical liquid injector according to a fourth embodiment of the present invention. [Figure 9] FIG. 11 is a functional schematic diagram of a roller pump of a liquid injector according to a fourth embodiment of the present invention. [Figure 10] FIG. 11 is a flowchart showing a liquid refilling sequence of the liquid injector according to another embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0013] Hereinafter, the present invention will be described in terms of the embodiments. The dimensions, materials, shapes, and relative positions of components are arbitrary and can be changed according to the configuration of the device to which the present invention is applied or various conditions. Furthermore, unless otherwise specified, the scope of the present invention is not limited to the embodiments specifically described below.
[0014] The present invention is a drug solution injection device for injecting a drug solution into a subject. The drug solution injection device includes a drug solution injector, a replacement pipe line section, a common pipe line section, a control device, and a flow blocking unit. The drug solution injector is a drug solution source having an opening, and holds the drug solution inside, and a drug solution supplying means discharges the drug solution from the opening. The replacement pipe line section is, for example, a tube-shaped pipe line connected to a puncture member such as a needle or a catheter that is introduced into the subject's blood vessel, and the drug solution flows inside the tube. This part is used on the premise that it will be replaced in short cycles for each patient. A common pipe line section is connected between the drug solution injector and the replacement pipe line section. The common pipe line section is not replaced for each patient, but is replaced in long cycles. The common pipe line section is, for example, a tube-shaped pipe line connected to the opening of the drug solution source and flows the drug solution from the drug solution injector to the replacement pipe line section. The control device is electrically connected to the chemical solution supplying means by wire or wirelessly, and sends a command to the chemical solution supplying means to control the driving of the chemical solution supplying means.
[0015] The flow cutoff unit is disposed in the replacement pipe section or in the pipe at the boundary between the replacement pipe section and the common pipe section. The flow cutoff unit is electrically connected to the control device by wire or wirelessly. The flow cutoff unit can be switched between an open state in which the flow of the liquid medicine is permitted and a closed state in which the flow of the liquid medicine is blocked, by the liquid medicine supply means receiving a command from the control device. The control device then sends a command to the flow cutoff unit to open the flow cutoff unit so as to permit the flow of the liquid medicine when the pressure in the common pipe section reaches a predetermined pressure higher than the intravascular pressure of the subject. On the other hand, the control device sends a command to the flow cutoff unit to close the flow of the liquid medicine when the pressure in the common pipe section falls below a predetermined pressure higher than the intravascular pressure of the subject.
[0016] As the drug injector, a type that pressurizes the drug from the upstream side and a type that pressure-feeds the drug by depressurizing the downstream side are applicable. As the type that pressurizes the drug from the upstream side, a syringe type, a type that uses a pressurizing device that pressurizes the inside of a container holding the drug to discharge the drug, and a type that uses a pressurizing device that pressurizes the inside of a container holding the drug to discharge the drug, are applicable. As the syringe type, a type that uses an outer cylinder that holds the drug and a drive motor that applies a pressing force to pressurize the drug with a piston inserted into the outer cylinder are applicable as the drug supply means. As the type that pressure-feeds the drug by depressurizing the downstream side, a type that pressurizes at least two points of the pipe of the common pipe section by a pressing part, a partition containing the drug is created between the narrowed part of the pipe, and the drug in the partition is moved by the drug supply means while being pressed from the drug source side, which is the upstream side, to the subject side, which is the downstream side.
[0017] The flow cut-off unit can be of a type that cuts off the flow of chemical solution by using a member to clamp the pipeline within the replacement pipeline section or at the boundary between the replacement pipeline section and the common pipeline section, or of a type that uses a cut-off valve placed within the pipeline.
[0018] As a method for determining the predetermined pressure for shutting off the shutoff valve, it is possible to directly measure the pressure in the liquid injector or the pressure in at least one of the replacement pipe section and the common pipe section with a pressure sensor. In addition, since it is inconvenient to use the liquid injector by disposing a pressure sensor to directly measure the pressure when injecting the liquid, a method of indirectly estimating the pressure in the pipe can also be used. For example, in the type using a syringe, it is possible to determine the predetermined pressure according to the value of an electric signal input to the drive motor when the drive motor is driven, or it is possible to provide a pressure detector between the drive motor and the piston and determine the predetermined pressure according to the electric signal output from the pressure detector. Next, this embodiment will be described below as specific examples.
[0019] (First embodiment) A first embodiment of the present invention will be described below with reference to Figs. 1 to 4. The first embodiment is a type of embodiment that employs a syringe. Fig. 1 shows an overall configuration diagram of a liquid injector 1a of the first embodiment. The liquid injector 1a includes a replacement pipe section 10, a liquid injector 20, a common pipe section 30, and a control device 40. The replacement pipe section 10 and the common pipe section 30 form a liquid injection pipe, and the replacement pipe section 10 is replaced for each subject, while the common pipe section 30 is used commonly by multiple subjects. The replacement pipe section 10 is a pipe area where the subject's body fluid may flow back, and the common pipe section 30 is defined as an area where the subject's body fluid does not flow back. In the liquid medicine injector 1a, the liquid medicine supplied from the liquid medicine injector 20 first flows into a common pipe section 30 which is a liquid medicine injection pipe line, and then flows from the common pipe section 30 to the replacement pipe section 10.
[0020] The replacement pipe section 10 is a line downstream of the common pipe section 30 among the drug injection pipes, and is on the subject side. The replacement pipe section 10 has an injection tube 12 at its downstream end that can be connected to a puncture member 11, such as a needle or a catheter, which is punctured or introduced into the subject's blood vessel to inject the drug solution into the subject and has a tubular interior through which the drug solution flows. On the other hand, the upstream end is bifurcated into a first supply tube 16 and a second supply tube 17. The first supply tube 16 and the second supply tube 17 are each connected to the input side of a mixing device 15, and a mixed supply tube 18 is connected to the output side of the mixing device 15. The first supply tube 16 and the second supply tube 17 on the opposite side to the side to which the mixing device 15 is connected are respectively connected to a first connection joint 16a and a second connection joint 17a. The chemical liquid from the first supply tube 16 and the chemical liquid from the second supply tube 17 are mixed in the mixing device 15 and flow into the mixed supply tube 18. The first supply tube 16, the second supply tube 17, and the mixed supply tube 18 are all made of flexible tubes. The injection tube 12 can be connected to the mixed supply tube 18 via a connector 12a. Instead of the mixing device 15, the connection can also be made via a T-shaped connector.
[0021] The replacement pipe section 10 has a T-connector 13 on the mixture supply tube 18, and the T-connector 13 branches off the mixture supply tube 18 into a monitor line 19 for detecting the subject's blood pressure and pulse. A port to which a pressure detector 14 can be connected is disposed at the tip of the monitor line 19, and detects the subject's blood pressure and pulse.
[0022] The liquid injector 20 includes a liquid source having an opening, and a liquid supply means for pressurizing the liquid and discharging the liquid from the opening. The liquid injector 20 is typically a syringe filled with the liquid. When the liquid injector 20 is a syringe, the liquid injector 20 can be a syringe having an outer cylinder that can be filled with the liquid as the liquid source, and a piston that can be inserted into the outer cylinder and move relative to the outer cylinder to press the liquid so as to push the liquid out of the opening. In this case, the liquid supply means can be a drive motor that applies a driving force to press the piston. A representative example of a syringe for injecting two liquids into a subject will be described below. The liquid injector 20 includes a first syringe 21 for supplying a contrast medium as a first liquid, and a second syringe 22 for supplying saline as a second liquid. The first syringe 21 has an outer cylinder 21a, the tip of which has an opening 21b for drawing in or discharging a first liquid medicine, and a piston 21c is inserted into the opening opposite opening 21b. The second syringe 22 has an outer cylinder 22a, the tip of which has an opening 22b for drawing in or discharging a second liquid medicine, and a piston 22c is inserted into the opening opposite opening 22b.
[0023] The liquid injector 20 includes a drive motor that applies a driving force to move the piston of the syringe as a liquid supplying means. In this embodiment, the drive motor includes a first motor 23 and a second motor 24. In order to make the first syringe 21 and the second syringe 22 replaceable, the first motor 23 and the piston 21c and the second motor 24 and the piston 22c are not directly connected to each other, and the first motor 23 is attached to the piston 21c of the first syringe 21 via a pressing member 25, and the second motor 24 is attached to the piston 22c of the second syringe 22 via a pressing member 26. The piston 21c of the first syringe 21 and the piston 22c of the second syringe 22 are pushed by the first motor 23 and the second motor 24 via the pressing member 25 and the pressing member 26, respectively, to move forward or backward. When the piston 21c of the first syringe 21 retracts, the first medicinal liquid is sucked into the outer cylinder 21a, and when the piston 21c of the first syringe 21 advances, the first medicinal liquid is discharged from the outer cylinder 21a. When the piston 22c of the second syringe 22 retracts, the second medicinal liquid is sucked into the outer cylinder 22a, and when the piston 22c of the second syringe 22 advances, the second medicinal liquid is discharged from the outer cylinder 22a.
[0024] The first motor 23 and the second motor 24 are, for example, typically direct current motors (DC motors). The liquid injector 20 has a control circuit 27, which controls the first motor 23 and the second motor 24, which are the drive motors, by pulse width modulation control (PWM control). By controlling the pulse width of the constant voltage pulse and the on / off duty of the pulse, an amount of power determined by the pulse width and the voltage on / off duty is applied to the drive motor, thereby controlling the rotation angle and rotation speed of the drive motor. The first motor 23 and the second motor 24 each perform a predetermined rotation according to the applied amount of power, and the forward speed, forward amount, retraction speed, and retraction amount of the pressing member 25 and the pressing member 26 are determined from the rotation angle and rotation speed. As a result, the piston 21c of the first syringe 21 and the piston 22c of the second syringe 22 move relative to the outer cylinder 21a and the outer cylinder 22a.
[0025] The common pipe section 30 is located upstream of the replacement pipe section 10 among the liquid medicine injection pipes. The common pipe section 30 includes a first liquid medicine line 31 through which a contrast medium flows as a first liquid medicine and a second liquid medicine line 32 through which physiological saline flows as a second liquid medicine. The downstream end of the first liquid medicine line 31 is detachably connected to the first connection joint 16a of the replacement pipe section 10, and is fluidically connectable to the first supply tube 16. On the other hand, the downstream end of the second liquid medicine line 32 is detachably connected to the second connection joint 17a of the replacement pipe section 10, and is fluidically connectable to the second supply tube 17. The first connection joint 16a and the second connection joint 17a are means for joining and separating the replacement pipe section 10 and the common pipe section 30.
[0026] The pipe of the first chemical liquid line 31 is branched by a T-shaped connector 33 in the middle, one end of the branched pipe is connected to the opening 21b of the first syringe 21, and the other end is connected to a first chemical liquid bag 34 in which the first chemical liquid is stored via a first chemical liquid valve 34a. When the first chemical liquid valve 34a is closed, the first chemical liquid bag 34 and the first chemical liquid line 31 are isolated, and when the first chemical liquid valve 34a is opened, the first chemical liquid bag 34 and the first chemical liquid line 31 are communicated with each other. Similarly, the second chemical liquid line 32 is branched by a T-shaped connector 35 in the middle, one end of which is connected to the opening 22b of the second syringe 22, and the other end of which is connected to a second chemical liquid bag 36 in which the second chemical liquid is stored via a second chemical liquid valve 36a. When the second chemical liquid valve 36a is closed, the second chemical liquid bag 36 is isolated from the second chemical liquid line 32, and when the second chemical liquid valve 36a is opened, the second chemical liquid bag 36 is connected to the second chemical liquid line 32. The first chemical liquid valve 34a and the second chemical liquid valve 36a do not have to be open / close valves, and each can be a one-way valve that allows only flow from the first chemical liquid bag 34 to the first chemical liquid line 31 while preventing flow from the first chemical liquid line 31 to the first chemical liquid bag 34, and allows only flow from the second chemical liquid bag 36 to the second chemical liquid line 32 while preventing flow from the second chemical liquid line 32 to the second chemical liquid bag 36. In this case, the first chemical liquid bag 34 always communicates with the first chemical liquid line 31 in a state where only flow from the first chemical liquid bag 34 to the first chemical liquid line 31 is permitted, and the second chemical liquid bag 36 always communicates with the second chemical liquid line 32 in a state where only flow from the second chemical liquid bag 36 to the second chemical liquid line 32 is permitted. By closing the downstream side of the first chemical liquid line 31 where the T-shaped connector 33 of the branching portion to the first chemical liquid bag 34 is located and the downstream side of the second chemical liquid line 32 where the T-shaped connector 35 of the branching portion to the second chemical liquid bag 36 is located, i.e., the first supply tube 16 and the second supply tube 17 or the mixed supply tube 18, a conduit through which the first chemical liquid flows from the first chemical liquid bag 34 to the first syringe 21 and a conduit through which the second chemical liquid flows from the second chemical liquid bag 36 to the second syringe 22 are formed.
[0027] The control device 40 includes a central processing unit (CPU) 41, an input device 42, a display device 43, and a storage device 44. The input device 42 allows the user to input necessary information, and the user can input the necessary information as shown on the display device 43. The input information is stored in the storage device 44. The control device 40 is electrically connected to the liquid injector 20 by wire or wirelessly. The central processing unit (CPU) 41 issues commands to the control circuit 27 of the liquid injector 20 according to the program stored in the storage device 44 and the information stored in the storage device. In this embodiment, the liquid injector 20 has the control circuit 27, but the liquid injector 20 does not have to have the control circuit 27. In this case, the control device 40 may have the central processing unit (CPU) 41 having the function of the control circuit 27, and the central processing unit (CPU) 41 may control the amount of power applied to the first motor 23 and the second motor 24.
[0028] A flow cutoff unit 5 is attached to the mixture supply tube 18. In this embodiment, the flow cutoff unit 5 is attached to the mixture supply tube 18 in the replacement pipe section 10, but the flow cutoff unit 5 may be disposed in the replacement pipe section 10 or at the boundary between the replacement pipe section 10 and the common pipe section 30, that is, in the replacement pipe section 10 up to the common pipe section 30. For example, the flow cutoff unit 5 may be disposed at the first connection joint 16a and the second connection joint 17a, which are the boundary between the replacement pipe section 10 and the common pipe section 30. The downstream of the flow cutoff unit 5 is the replacement pipe section 10, which is a pipe area where the subject's body fluid may flow back, and the common pipe section 30 is located upstream of the flow cutoff unit 5 as an area where the subject's body fluid does not flow back. That is, in FIG. 1, the flow cutoff unit 5 is described as being located downstream of the mixing device 15 as an example, but the positional relationship between the flow cutoff unit 5 and the mixing device 15 does not matter. The flow cutoff unit 5 can be switched between an open state that allows the flow of the chemical liquid in the mixture supply tube 18 before and after the mixture supply tube 18 and a closed state that blocks the flow of the chemical liquid in the mixture supply tube 18 before and after the mixture supply tube 18 by the driving force of the driving means 6. The flow cutoff unit 5 can be in any form as long as it can be switched between an open state that allows the flow of the chemical liquid in the mixture supply tube 18 before and after the mixture supply tube 18 and a closed state that blocks the flow of the chemical liquid in the mixture supply tube 18 before and after the mixture supply tube 18. When the flow cutoff unit 5 is in the closed state, the flow of the pipe upstream of the flow cutoff unit 5 is isolated from the flow of the pipe downstream of the flow cutoff unit 5 by the flow cutoff unit 5, and the flow downstream of the flow cutoff unit 5 does not flow back to the upstream of the flow cutoff unit 5. The driving means 6 is electrically connected to the control device 40 by wire or wirelessly, and the control device 40 can switch the flow cutoff unit 5 between the open state and the closed state in response to a command from a central processing unit (CPU) 41. The flow interruption unit 5 can be, for example, in the following form:
[0029] The flow interruption unit 5 can be, for example, a flow interrupter 51 in which the mixture supply tube 18 is placed between two block members 51a and 51b arranged opposite to each other. FIG. 2A shows a cross-sectional view of an example of the interrupter 51. The flow interrupter 51 can be switched between an open state (solid line) in which the block members 51a and 51b are positioned farther away than the diameter of the mixture supply tube 18 to allow flow in the mixture supply tube 18, and a closed state (dotted and dashed lines) in which the block members 51a and 51b are closer than the diameter of the mixture supply tube 18 to sandwich the mixture supply tube 18 and stop the flow in the mixture supply tube 18. The block members 51a and 51b can be moved by the driving means 6 between a distance at which the block members 51a and 51b are in the open state (solid line) and a distance at which the block members 51a and 51b are in the closed state (dotted and dashed lines). As the driving means 6 for supplying a driving force to the block members 51a and 51b, various driving means 6 can be used as long as the block members 51a and 51b can be moved so that the chemical solution can be blocked in a short time. For example, a device that applies a driving force by electromagnetic force, or a device that applies a driving force by mechanical force such as liquid pressure or a motor can be used. The flow interrupting unit 5 can be an integral device with the driving means 6, or can be a separate device. This makes it possible to stop the flow of the drug solution in the mixture supply tube 18 before and after the mixture supply tube 18. A plurality of flow interrupters 51 may be arranged on the mixture supply tube 18 along the extending direction of the mixture supply tube 18. In this case, when the drug solution is opened to be injected into the subject, a sequence may be taken in which the flow interrupting units 5 are opened in sequence from the drug solution source side, which is the upstream side, toward the subject side, which is the downstream side. In addition, when the drug solution is injected into the subject and then closed, a sequence may be taken in which the flow interrupting units 5 are closed in sequence from the subject side, which is the downstream side, toward the drug solution source side, which is the upstream side.
[0030] Also, the flow shutoff unit 5 can be, for example, a shutoff valve 52 disposed between the flow of the mixture supply tube 18. FIG. 2B shows a cross-sectional view of an example of the shutoff valve 52 in a closed state. The shutoff valve 52 includes, for example, a first piston 52a and a second piston 52b. The first piston 52a and the second piston 52b are received and supported by a valve housing so as to be movable in a direction perpendicular to the flow direction of the mixture supply tube 18. The first piston 52a is provided with a flow passage 52c extending along the flow direction of the mixture supply tube 18, and the second piston 52b is provided with a flow passage 52d extending along the flow direction of the mixture supply tube 18. The first piston 52a is disposed between the flow of the mixture supply tube 18 so that the side of the first piston 52a is the downstream side of the drug injection conduit, i.e., the subject side, and the side of the second piston 52b is the upstream side of the drug injection conduit, i.e., the drug side. The cross-sectional area of the flow passage 52c is smaller than the cross-sectional area of the flow passage 52d. When the first piston 52a and the second piston 52b are at a predetermined position where the flow path 52c, the flow path 52d, and the flow path of the mixture supply tube 18 are aligned, the state is an open state (not shown) that allows the flow in the mixture supply tube 18. When the first piston 52a and the second piston 52b move in a direction perpendicular to the flow path of the mixture supply tube 18 and the flow paths 52c, the flow path 52d, and the flow path of the mixture supply tube 18 are not aligned, the state is a closed state (the state of FIG. 2B). The first piston 52a and the second piston 52b can be moved between an open state and a closed state by the driving means 6. As the driving means 6 that supplies a driving force to the first piston 52a and the second piston 52b, various types of driving means can be used as long as they can move the first piston 52a and the second piston 52b so that the drug solution can be blocked in a short time. For example, a driving force that is applied electromagnetically, or a driving force that is applied mechanically by liquid pressure or a mechanism can be used. The flow shutoff unit 5 can be an integral device with the driving means 6, or can be a separate device. In this way, even if a shutoff valve 52 driven by the driving means 6 is used, it is possible to stop the flow of the liquid medicine in the mixing supply tube 18 before and after the mixing supply tube 18.Here, the shutoff valve 52 is described as an example in which two pistons, the first piston 52a and the second piston 52b, are arranged, but the shutoff valve may also be one in which one or more pistons are arranged. In addition, when two or more pistons are arranged, a plurality of pistons are arranged on the mixture supply tube 18 along the extending direction of the mixture supply tube 18. In this case, when opening the valve to inject the drug solution into the subject, a sequence may be taken in which the pistons are opened in order from the drug solution source side, which is the upstream side, toward the subject side, which is the downstream side. In addition, when closing the valve after injecting the drug solution into the subject, a sequence may be taken in which the pistons are closed in order from the subject side, which is the downstream side, toward the drug solution source side, which is the upstream side.
[0031] Next, referring to Fig. 3A and Fig. 3B, how the flow blocking unit 5 is driven by the driving means 6 by the control device 40 to prevent backflow of the subject's body fluid in the replacement pipe section 10 will be described. For simplicity, it is assumed that the liquid injection sequence is such that the liquid injection is completed when the liquid filled in the first syringe 21 or the second syringe 22 runs out after the puncture member 11 is pierced into the subject and the liquid injection is started. Fig. 3A shows the history of pressure in the pipe at an arbitrary position (D1 in Fig. 1) of the replacement pipe section 10 in Fig. 1. Fig. 3B is a diagram showing a flow chart of the liquid injection process of the liquid injection device of the present invention. In FIG. 3A, when the flow resistance in the conduit is taken into consideration, the pressure in the conduit at an arbitrary position (D2 in FIG. 1) in the common conduit section 30 in FIG. 1 is different in terms of pressure value, but the tendency of the pressure change is almost the same as that in FIG. 3A. Also, the pressure inside the first syringe 21 or the second syringe 22 close to the arbitrary position (D2 in FIG. 1) in the common conduit section 30 is almost the same as the tendency of the pressure history in FIG. 3A. The horizontal axis of FIG. 3A indicates the passage of time, and the vertical axis indicates the gauge pressure with the intravascular pressure of the subject as the zero reference. First, in the preparation stage, the flow blocking unit 5 is in a closed state, and at this stage, the first syringe 21 or the second syringe 22 is filled with the drug solution and the preparation is completed. Here, the puncture member 11 is punctured into the subject (S1). Only when the flow blocking unit 5 is in a closed state, the puncture member 11 can be punctured into the subject.
[0032] With the flow blocking unit 5 in a closed state, a command is issued from the central processing unit (CPU) 41 of the control device 40 to the first motor 23 and the second motor 24 to rotate. The first motor 23 and the second motor 24 that receive the command advance the piston 21c of the first syringe 21 or the piston 22c of the second syringe 22 in a predetermined sequence. This causes the pressure in the drug solution injection pipeline including the first syringe 21 or the second syringe 22 to gradually increase (S2). It is determined whether the pressure in the first syringe 21 or the second syringe 22 has increased to a predetermined pressure (Psafe) higher than the subject's intravascular pressure when the subject's intravascular pressure is set as a zero reference. If it has not reached this level, the pistons 21c and 22c are advanced, and the pressure in the drug solution injection pipeline including the first syringe 21 or the second syringe 22 is gradually increased (S3). For example, this predetermined pressure is about several tens of kilopascals [kPa] (several pounds per square inch [psi]). In particular, when the pressure is about 0.14 megapascals [MPa] (about 20 pounds per square inch [psi]), the certainty of preventing backflow is increased, but this value is not a limiting factor for the predetermined pressure. At this stage, the pressure in the common pipe section 30 is higher than that of the replacement pipe section 10. At the stage when the pressure in the drug injection pipe increases to the predetermined pressure (Psafe) (time T1 has elapsed), the control device 40 sends a command to the drive means 6 to open the flow blocking unit 5, which is in the closed state (S4). From this state, the subject's body fluid will not flow back to the common pipe section 30.
[0033] Since the flow shutoff unit 5 is changed to the open state, the liquid medicine rapidly flows into the downstream volume of the flow shutoff unit 5 where the liquid medicine had not been introduced, so that the pressure in the liquid medicine injection pipeline decreases once in an extremely short time, but the pressure starts to rise immediately thereafter. Then, at the stage where the pressure reaches the target injection pressure (Ptarget) (at the time when time T2 has elapsed), the rotation speed of the first motor 23 and the second motor 24 is reduced, and the liquid medicine is injected at a constant speed. While there is a sufficient amount of liquid medicine remaining in the first syringe 21 or the second syringe 22, the pressure in the liquid medicine injection pipeline shows a pressure history that changes almost constantly depending on the amount of remaining liquid medicine (any time until the time T3). At the stage where the initially planned amount of liquid medicine has been injected, the rotation of the first motor 23 and the second motor 24 is stopped, and the injection of the liquid medicine is completed (S5). By stopping the rotation of the first motor 23 and the second motor 24, the injection of the liquid medicine is left to a natural flow to the subject, and the pressure in the liquid medicine injection pipeline gradually decreases. Here, a command is sent to the driving means 6 so that the flow cutoff unit 5 is in a closed state to cut off the flow of the medicinal liquid (S7). The process (S5) for determining whether a predetermined amount of medicinal liquid has been injected does not need to be provided, and the completion of the injection of the medicinal liquid is determined when the predetermined amount of medicinal liquid has been injected. When the injection of the medicinal liquid is completed when the predetermined amount of medicinal liquid has been injected, the control device 40 sends a command to the driving means 6 so that the flow cutoff unit 5 is in a closed state to cut off the flow of the medicinal liquid (S7). This is the case in many cases of the process of injecting medicinal liquid. In this state, the subject's body fluid does not flow back upstream of the flow cutoff unit 5, that is, at least to the most downstream of the common pipe section 30.
[0034] On the other hand, when the predetermined amount of the liquid medicine has not yet been injected, the injection of the liquid medicine is continued (S5). In many cases, this is an abnormal state, such as a shortage of the amount of the liquid medicine filled or a leakage of the liquid medicine, but when the amount of the liquid medicine in the first syringe 21 or the second syringe 22 decreases, the pressure in the liquid medicine injection line including the first syringe 21 or the second syringe 22 shows a decreasing pressure history (from the time T3 to the time T4) when the pressure in the liquid medicine injection line becomes a predetermined pressure (Psafe) (at the time T4) (S6), the control device 40 sends a command to the drive means 6 to close the flow cutoff unit 5, which is in the open state. At this stage, the pressure in the common pipe section 30 is higher than that on the replacement pipe section 10 side. In this state, the subject's body fluid does not flow back upstream of the flow cutoff unit 5, that is, at least to the most downstream of the common pipe section 30. In this state, the common conduit section 30 is removed from the replacement conduit section 10. That is, the control device 40 sends a command to the drive means 6 so that the flow cutoff unit 5 goes into an open state in which the medicinal liquid flows when the pressure in the syringe reaches a predetermined pressure (Psafe) higher than the intravascular pressure of the subject, and goes into a closed state in which the flow of the medicinal liquid is cut off when the pressure in the syringe falls below the predetermined pressure (Psafe) (S7).
[0035] The timing when the control device 40 sends the command for the step (S3) of opening the flow cutoff unit 5 to allow the flow of the liquid medicine and the step (S7) of closing the flow cutoff unit 5 to cut off the flow of the liquid medicine is the timing when it is determined that the predetermined pressure (Psafe) has been reached. Therefore, various methods can be used to determine that the predetermined pressure (Psafe) has been reached. For example, the intravascular pressure of a human is at most about 130 millimeters of mercury (897 kilopascals [kPa]) (about 2.51 pounds per square inch [psi]), and the individual variation from subject to subject is at most 30 millimeters of mercury (4 kilopascals [kPa]) (about 0.57 pounds per square inch [psi]), which is smaller than the predetermined pressure (Psafe) which is higher by several tens of kilopascals [kPa] (several pounds per square inch [psi]). Therefore, the control device 40 uniquely assumes that the intravascular pressure of a human is a predetermined value, and when it is estimated that the intravascular pressure has reached a predetermined pressure (Psafe) that is about several tens of kilopascals [kPa] (several pounds per square inch [psi]) higher than the assumed intravascular pressure without measuring the pressure at all, the control device 40 sends a command to the flow blocking unit 5 to open the flow blocking unit 5 to allow the flow of the medicinal liquid or close the flow blocking unit 5 to block the flow. For example, in the case of injection of the medicinal liquid into the subject, the flow blocking unit 5 is opened after a first predetermined time has elapsed since the start of injection of the medicinal liquid. In addition, in the case of completion of injection of the medicinal liquid into the subject, a command to close the flow blocking unit 5 may be sent after a second predetermined time has elapsed since the completion of injection of the medicinal liquid. The first predetermined time is the time during which a predetermined pressure is applied so that the pressure in the common conduit portion becomes high with the flow blocking unit 5 in the closed state that blocks the flow of the medicinal liquid. More specifically, the first predetermined time is a time for increasing the pressure in the drug injection pipeline up to the flow cutoff unit 5 to a predetermined pressure by flowing a small amount of drug solution at a predetermined injection rate with the flow cutoff unit 5 in a closed state as a pressurization phase before actually injecting the drug solution into the subject, from a state in which no drug solution is flowing in the pipeline at all, to the flow cutoff unit 5. The predetermined injection rate is, for example, an injection rate slower than the injection rate of the drug solution into the subject. The second predetermined time is a certain time when the pressure in the common pipe section is kept high at the same time as the supply of the liquid medicine from the liquid medicine injector is completed or when the flow blocking unit is in a closed state blocking the flow of the liquid medicine. Specifically, the certain time from the completion of the liquid medicine injection as the second predetermined time is determined based on a preliminary measurement performed in advance as a time when the pressure reduction rate can be predicted and the rate is grasped in advance and a predetermined pressure (Psafe) that is about several tens of kilopascals [kPa] (several pounds square inches [psi]) higher than the assumed intravascular pressure can be ensured after the completion of the liquid medicine injection. In addition, in the case of the second predetermined time at the same time as the completion of the liquid medicine injection, it is ensured that the predetermined pressure (Psafe) is about several tens of kilopascals [kPa] (several pounds square inches [psi]) higher than the intravascular pressure immediately after the liquid medicine injection is completed. Since the pressure decreases from this point after the liquid medicine injection, the highest pressure is ensured immediately after the liquid medicine injection is completed. Therefore, by operating the flow cutoff unit 5 in this manner using the control device 40, the subject's body fluid will not flow back upstream of the flow cutoff unit 5, that is, at least to the most downstream position of the common conduit portion 30.
[0036] For example, a sequence when injecting a liquid medicine and after the injection of the liquid medicine will be described with reference to a case where the flow cutoff unit 5 is a cutoff valve 52 disposed in the flow of the mixed supply tube 18. First, the flow cutoff unit 5 is in a closed state as shown in FIG. 2B, in which the flow path 52c of the first piston 52a and the flow path 52d of the second piston 52b are not communicated with each other and the flow of the liquid medicine is cut off. This state is before the start of the liquid medicine injection, in which the liquid medicine has not yet reached the flow cutoff unit 5. Next, the flow cutoff unit 5 is maintained in a closed state, and a pressurization phase is executed in which a low amount of liquid medicine flows at a predetermined injection rate until it reaches the flow cutoff unit 5. The predetermined injection rate is, for example, an injection rate slower than the injection rate of the liquid medicine into the subject. For example, in this pressurization phase, for example, 0.3 milliliters of liquid medicine flows at a rate of 2 milliliters per second for 150 milliseconds until the liquid medicine reaches the flow cutoff unit 5. 10 milliseconds after the start of this pressurization phase, the flow cutoff unit 5 is switched to an open state. The 10 milliseconds after this corresponds to the first predetermined time. That is, when the first predetermined time of 10 milliseconds has elapsed after the start of supplying the drug from the drug injector 20, the flow cutoff unit 5 is opened to allow the flow of the drug. Here, for example, the flow path 52d of the second piston 52b on the upstream side is first opened, and then the flow path 52c of the first piston 52a on the downstream side is opened. That is, in this sequence when two or more pistons are used as the cutoff valve 52, the pistons are opened from the upstream side, so that the flow cutoff unit 5 is in a completely open state with the most downstream piston open. On the other hand, conversely, after the injection of the drug, the first motor 23 and the second motor 24 are stopped first after the injection is completed. This is the timing of the completion of the injection, and the flow cutoff unit 5 is closed after the second predetermined time has elapsed from this point. That is, first, the flow cutoff unit 5 is closed at the same time as the first motor 23 and the second motor 24 are stopped or after a certain time has elapsed. In general, for example, the flow passage 52c of the first piston 52a on the downstream side is closed after a certain time, for example, several milliseconds to several seconds, has elapsed after the first motor 23 and the second motor 24 are stopped. Then, the flow passage 52d of the second piston 52b on the upstream side is closed, and the flow blocking unit 5 is put into a closed state.In this sequence when the shutoff valve 52 uses two or more pistons, the pistons are closed from the downstream side, so that the flow shutoff unit 5 is in a completely closed state with the most upstream piston open. In the above, an example was described in which the timing of closing the pistons is shifted when two or more pistons are used as the shutoff valve 52, but a timing in which all the pistons are simultaneously opened or closed may be used. For example, in the case of a shutoff valve 52 having two or more pistons constituting the shutoff valve 52, the cross-sectional area of the flow path 52d of the upstream second piston 52b is set to be larger than the cross-sectional area of the flow path 52c of the first piston 52a when the drug solution is injected, so that when the first piston 52a and the second piston 52b are driven simultaneously, the flow path 52d of the upstream second piston 52b first communicates, and then the flow path 52c of the downstream first piston 52a communicates. On the other hand, conversely, after the injection of the drug solution, the first piston 52a and the second piston 52b can be driven simultaneously after a certain time has elapsed since the injection is completed and the first motor 23 and the second motor 24 are stopped, so that the flow passage 52c of the first piston 52a on the downstream side is first closed, and then the flow passage 52d of the second piston 52b on the upstream side is closed to close the flow cutoff unit 5. That is, by adjusting the timing of the operation of the first piston 52a and the second piston 52b and the cross-sectional area of the flow passage 52c of the first piston 52a and the cross-sectional area of the flow passage 52d of the second piston 52b in this way, when the cutoff valve 52 is opened, the flow passages can be made to communicate in order from the upstream side to the downstream side of the pistons constituting the cutoff valve 52, and when the cutoff valve 52 is closed, the flow passages can be made to close in order from the downstream side to the upstream side of the pistons constituting the cutoff valve 52.
[0037] The timing of sending the command of the step (S3) of the control device 40 opening the flow cutoff unit 5 to allow the flow of the liquid medicine and the step (S7) of the flow cutoff unit 5 closing to cut off the flow of the liquid medicine can be determined by directly measuring the human blood vessel pressure with a pressure sensor or the like, instead of the method of assuming the human blood vessel pressure as a predetermined value uniquely without measuring any pressure as described above. For example, the simplest method is to measure the subject's blood vessel pressure by arranging the pressure detector 14 at a port of the monitor line 19 that detects the subject's blood pressure and pulse. That is, the pressure detector 14 is arranged at an arbitrary position of either the replacement pipe section 10 or the common pipe section 30. Any type of pressure sensor can be used as the pressure detector 14, and a representative example is a pressure sensor such as a semiconductor pressure sensor or a piezoelectric element. In this case, the closer the pressure detector 14 is to the subject, the more accurate the measurement of the subject's blood vessel pressure can be achieved, but it is not necessary to measure the subject's blood vessel pressure accurately. It is sufficient to know that the pressure in the drug injection pipeline is higher than the intravascular pressure of the subject. Therefore, the pressure detector 14 may be disposed in the vicinity of the first syringe 21 or the second syringe 22 to directly measure the pressure. It is also possible to determine a predetermined pressure (Psafe) from the electrical signal output by the pressure detector 14, and based on the detection of an electrical signal corresponding to the predetermined pressure (Psafe) by the pressure detector 14, the control device 40 may send a command to the flow cutoff unit 5 to open the flow cutoff unit 5 to allow the flow of the drug solution or close the flow cutoff unit 5 to allow the flow of the drug solution.
[0038] Furthermore, the pressure in the liquid medicine injection pipeline does not need to be measured directly for the timing when the control device 40 sends a command for the step (S3) of opening the flow cutoff unit 5 to allow the flow of the liquid medicine and the step (S7) of closing the flow cutoff unit 5 to cut off the flow of the liquid medicine. That is, a predetermined pressure (Psafe) may be determined according to a value corresponding to the amount of electric power input to the drive motors 23 and 24 to drive the drive motors. In addition, in the case of PWM control using a constant voltage pulse, the amount of electric power input to the drive motor is proportional to the current input to the drive motor, so that the value corresponding to the amount of electric power input to the drive motor in determining the pressure in the liquid medicine injection pipeline can be the value of the current input to the drive motor. Therefore, the value corresponding to the amount of electric power input to the drive motor includes the value of the current input to the drive motor. Here, for example, the relationship between the value corresponding to the amount of electric power input to each of the first motor 23 and the second motor 24 and the pressure in the liquid medicine injection pipeline is acquired as data in advance. The rotation speeds and rotation angles of the first motor 23 and the second motor 24 correspond to electrical signals having values corresponding to the amount of power (including values corresponding to current) output from the central processing unit 41 of the control device 40, so that corresponding data showing the relationship between the electrical signals and the pressure in the liquid injection pipeline is created and stored in the storage device 44. Then, with the flow interruption unit 5 in the closed state, the first motor 23 and the second motor 24, upon receiving a command from the control device 40, advance the piston 21c of the first syringe 21 or the piston 22c of the second syringe 22 in a predetermined sequence. Here, the central processing unit 41 of the control device 40 determines the pressure in the liquid injection pipeline from the electrical signals input to the first motor 23 and the second motor 24 when driving the first motor 23 and the second motor 24 (electrical signals corresponding to the amount of power or current input to the drive motors) as shown in FIG. 3A. When the electric signal input to the first motor 23 and the second motor 24 indicates that the pressure in the drug injection pipeline has reached a value corresponding to a predetermined pressure (Psafe) (time T1 has elapsed), the pressure in the common pipeline section 30 becomes higher than that in the replacement pipeline section 10. Then, the control device 40 sends a command to the drive means 6 to open the flow blocking unit 5, which is in the closed state.In this state, the subject's body fluid does not flow backward upstream of the flow cutoff unit 5, that is, at least to the most downstream of the common conduit portion 30.
[0039] The reverse is also true. That is, when the liquid medicine in the first syringe 21 or the second syringe 22 runs out, the pressure in the liquid medicine injection pipeline including the first syringe 21 or the second syringe 22 starts to drop (at the time T3). When it is determined from the electric signal transmitted to the first motor 23 and the second motor 24 that the pressure in the liquid medicine injection pipeline has reached a predetermined pressure (Psafe) (at the time T4), the control device 40 sends a command to the driving means 6 to close the flow interruption unit 5, which is in the open state. At this stage, the pressure in the common pipeline section 30 becomes higher than that on the replacement pipeline section 10 side. In this state, the subject's body fluid does not flow back to the common pipeline section 30. The common pipeline section 30 can be removed from the replacement pipeline section 10 in this state.
[0040] As a method of not directly measuring the pressure in the liquid injection pipeline, there is also a method of not using an electric signal transmitted to the first motor 23 and the second motor 24, which are the driving motors. FIG. 4 shows a part of the liquid injection device 20 in FIG. 1. As shown in FIG. 4, in the method of not using an electric signal, a pressing force detector is disposed on a pressing member that directly presses the piston of the syringe. As a pressing force detector, for example, a load cell is a simple device, but it also includes a strain gauge that is attached to the pressing member and indirectly measures the pressing force based on an electric signal output based on the strain amount of the pressing member, similar to the principle of the load cell. With such a pressing force detector, the pressing force with which the motor presses the piston can be obtained from the electric signal output by the pressing force detector when the motor presses the pressing member. First, the correspondence between the electric signal output by the pressing force detector when the motor presses the piston and the pressure in the liquid injection pipeline including the syringe is measured in advance. This correspondence corresponds to the correspondence between the pressing force with which the motor presses the piston and the pressure in the liquid injection pipeline including the syringe. From this correspondence, the pressure in the liquid injection pipeline including the syringe is determined based on the electrical signal output from the pressing force detector. That is, to use a load cell as the pressing force detector, the following procedure is followed. A load cell 28 and a load cell 29 are attached to pressing member 25 that presses piston 21c of first syringe 21 so that first motor 23 moves piston 21c, and pressing member 26 that moves piston 22c of second syringe 22 by second motor 24, respectively. The relationship between the electrical signal output from load cell 28 and the pressure in the liquid injection pipeline is obtained in advance, and the corresponding data is stored in storage device 44. The pressure in the liquid injection pipeline is determined based on this electrical signal. Specifically, first, the flow blocking unit 5 is in a closed state, and upon receiving commands from the control device 40, the first motor 23 and the second motor 24 move through the outer cylinder 21a and the outer cylinder 22a while pressing the piston 21c of the first syringe 21 and the piston 22c of the second syringe 22, respectively, in a predetermined sequence via the pressing members 25 and 26.At this time, the load cell 28 and the load cell 29 output an electric signal in response to the pressing force of the first motor 23 pressing the piston 21c of the first syringe 21 and the pressing force of the second motor 24 pressing the piston 22c of the second syringe 22. The pressure in the liquid injection line is determined from this electric signal as shown in FIG. 3A. When the electric signal indicates that the pressure in the liquid injection line has reached a value corresponding to a predetermined pressure (Psafe) (time T1 has elapsed), the pressure in the common line section 30 becomes higher than that of the replacement line section 10. Then, the control device 40 sends a command to the drive means 6 to open the flow blocking unit 5, which is in the closed state. In this state, the subject's body fluid does not flow back upstream of the flow blocking unit 5, that is, at least to the most downstream of the common line section 30.
[0041] The reverse is also true. That is, when the liquid medicine in the first syringe 21 or the second syringe 22 runs out, the pressure in the liquid medicine injection pipeline including the first syringe 21 or the second syringe 22 starts to drop (at the time when time T3 has elapsed). The strain amount with which the first motor 23 and the second motor 24 press the pistons 21c and 22c is determined from the electric signal output by the load cell 28 and the load cell 29, and when it is determined from the electric signal that the pressure in the liquid medicine injection pipeline has reached a predetermined pressure (Psafe) (at the time when time T4 has elapsed), the control device 40 sends a command to the drive means 6 to close the flow interruption unit 5, which is in the open state. At this stage, the pressure in the common pipeline section 30 becomes higher than that on the replacement pipeline section 10 side. In this state, the subject's body fluid does not flow back to the common pipeline section 30. The common pipeline section 30 can be removed from the replacement pipeline section 10 in this state.
[0042] (Second Example) The liquid injector 20 may be in a form other than a syringe. A second embodiment of the liquid injector 20 in a form other than a syringe will be described below with reference to FIG. 5. The second embodiment is a type of embodiment in which a pressurizing device that pressurizes the inside of a container holding the liquid and discharges the liquid is used as a liquid supplying means. FIG. 5 shows an overall configuration diagram of a liquid injector 1b of the second embodiment. The liquid injector 1b is the same as the first embodiment in that it includes a replacement pipe section 10, a liquid injector 20, a common pipe section 30, and a control device 40, and is also the same in that the liquid supplied from the liquid injector 20 first flows into the common pipe section 30, which is a liquid injection pipe, and then flows from the common pipe section 30 to the replacement pipe section 10. In the second embodiment, the replacement pipe section 10 and the common pipe section 30 also form a drug solution injection pipe, the replacement pipe section 10 is replaced for each subject, while the common pipe section 30 is used commonly by a plurality of subjects. The following describes the second embodiment, focusing on the differences from the first embodiment. Other than that, the configuration of the first embodiment can be applied as is.
[0043] In the liquid injector 1a of the first embodiment, the liquid injector 20 is in the form of a syringe, but in the second embodiment, the liquid sources of the liquid injector 20 are a first container 61 for supplying a contrast medium as a first liquid and a second container 62 for supplying physiological saline as a second liquid. The first container 61 and the second container 62 may each be a hard resin container or a flexible bag-shaped resin container. The material is not important. The liquid supply means of the liquid injector 20 are a first pressure pump 63 and a second pressure pump 64 that pressurize the first container 61 and the second container 62, respectively. The control circuit 27 is the same as in the first embodiment, and the first pressure pump 63 and the second pressure pump 64 are controlled by the control circuit 27. The first pressure pump 63 and the second pressure pump 64 pressurize the first chemical liquid in the first container 61 and the second chemical liquid in the second container 62 through the pressure port 61 a of the first container 61 and the pressure port 62 a of the second container 62 .
[0044] The configurations of the replacement pipeline section 10 and the control device 40 are the same as those in the first embodiment. The configuration of the common pipeline section 30 is almost the same as that in the first embodiment, but differs from the first embodiment in that the first liquid medicine bag 34 is not connected to the pipeline of the first liquid medicine line 31, and the second liquid medicine bag 36 is not connected to the pipeline of the second liquid medicine line 32. The rest is the same as the first embodiment, including the presence of the first liquid medicine line 31 through which a contrast medium flows as the first liquid medicine and the second liquid medicine line 32 through which physiological saline flows as the second liquid medicine.
[0045] An opening 61b in the first container 61 is fluidly connected to the first chemical liquid line 31, and an opening 62b in the second container 62 is fluidly connected to the second chemical liquid line 32. The control for the operation of the first pressurizing pump 63 and the second pressurizing pump 64 by the control device 40 is the same as in the first embodiment. That is, the first pressurizing pump 63 and the second pressurizing pump 64, which receive commands from the control device 40, pressurize the first container 61 and the second container 62 in a predetermined sequence. Here, the central processing unit 41 of the control device 40 determines the pressure in the chemical liquid injection pipeline from the electric signals input to the first pressurizing pump 63 and the second pressurizing pump 64 when driving the first pressurizing pump 63 and the second pressurizing pump 64 (electrical signals corresponding to the amount of power or current input to each pressurizing pump), as in the first embodiment, as shown in FIG. 3A. When the electric signal input to the first pressurizing pump 63 and the second pressurizing pump 64 indicates that the pressure in the drug solution injection pipeline has reached a value corresponding to a predetermined pressure (Psafe) (time T1 has elapsed), the pressure in the common pipeline section 30 becomes higher than that in the replacement pipeline section 10. Then, the control device 40 sends a command to the driving means 6 to open the flow cutoff unit 5, which is in the closed state. In this state, the subject's body fluid does not flow back upstream of the flow cutoff unit 5, that is, at least to the most downstream of the common pipeline section 30.
[0046] The reverse is also true. That is, when the respective medicinal liquids in the first container 61 or the second container 62 run out, the pressure in the medicinal liquid injection pipeline including the first container 61 or the second container 62 starts to drop (at the time T3 has elapsed). When it is determined from the electric signal transmitted to the first pressure pump 63 and the second pressure pump 64 that the pressure in the medicinal liquid injection pipeline has reached a predetermined pressure (Psafe) (at the time T4 has elapsed), the control device 40 sends a command to the driving means 6 to close the flow interruption unit 5, which is in the open state. At this stage, the pressure in the common pipeline section 30 becomes higher than the replacement pipeline section 10 side. In this state, the subject's body fluids do not flow back to the common pipeline section 30. The common pipeline section 30 can be removed from the replacement pipeline section 10 in this state. As a result, in the second embodiment as well, it is possible to create a timing at which the pressure in the common pipeline section 30 becomes higher than the replacement pipeline section 10 side, as in the first embodiment.
[0047] (Third Example) When the first container 61 and the second container 62 of the liquid injector 20 are flexible bag-shaped resin containers, the following embodiment can be adopted. Hereinafter, the third embodiment will be described with reference to Fig. 6, Fig. 7A, and Fig. 7B. The third embodiment is a type of embodiment in which a pressurizing device that pressurizes the inside of a container holding a liquid medicine by pressing the outside of the container to discharge the liquid medicine is used as a liquid medicine supplying means. The third embodiment is a modification of the second embodiment. Fig. 6 shows an overall configuration diagram of a liquid medicine injector 1c of the third embodiment. The liquid medicine injector 1c is the same as the first embodiment in that it includes a replacement pipe section 10, a liquid medicine injector 20, a common pipe section 30, and a control device 40, and is also the same in that the liquid medicine supplied from the liquid medicine injector 20 first flows into the common pipe section 30, which is a liquid medicine injection pipe, and then flows from the common pipe section 30 to the replacement pipe section 10. In the third embodiment, the replacement pipe section 10 and the common pipe section 30 also form a drug solution injection pipe, the replacement pipe section 10 is replaced for each subject, while the common pipe section 30 is used commonly by a plurality of subjects. The following describes the third embodiment, focusing on the differences from the second embodiment. Other than that, the configuration of the second embodiment can be applied as is.
[0048] In the third embodiment of the drug solution injector 1c, the drug solution supplying means is not a pressure pump but a pressurizing means for pressing a container to apply pressure. In the second embodiment, the inside of the drug solution source container is pressurized to first feed the drug solution into the common pipe section 30, which is the drug solution injection pipe line, and then the drug solution is fed from the common pipe section 30 to the replacement pipe section 10. In contrast, in the third embodiment, the drug solution source container is pressurized from the outside to first feed the drug solution into the common pipe section 30, which is the drug solution injection pipe line, and then the drug solution is fed from the common pipe section 30 to the replacement pipe section 10. That is, in the third embodiment, the drug solution sources of the drug solution injector 20 are a first container 71 for feeding a contrast medium as the first drug solution, and a second container 72 for feeding physiological saline as the second drug solution. Each of the first container 71 and the second container 72 is typically a flexible bag-shaped container, typically a resin bag, but the material is not limited. As shown in FIG. 7A, the liquid medicine supplying means of the liquid medicine injector 20 is a first pressurizing body 73 and a second pressurizing body 74, which are pressurizing means for pressurizing the first container 71 and the second container 72, respectively. The first pressurizing body 73 and the second pressurizing body 74 are roller-shaped members driven by the power of a motor or the like, and while pressing the first container 71 and the second container 72, which are flexible, they crush the first container 71 and the second container 72 and move in the direction of the openings 71a and 72a. The control circuit 27 is the same as that of the first embodiment, and the first pressurizing body 73 and the second pressurizing body 74 are controlled by the control circuit 27. When the first pressurizing body 73 and the second pressurizing body 74 crush the first container 71 and the second container 72, the pressure of the liquid medicine in the first container 71 and the second container 72 increases, and the first liquid medicine in the first container 71 and the second liquid medicine in the second container 72 flow. In addition, the first pressurizing body 73 and the second pressurizing body 74 may be configured to increase the internal pressure of a compressible fluid such as air sealed in a flexible bag-like container capable of changing volume, thereby pressing and compressing the first container 71 and the second container 72 through the change in volume, thereby increasing the pressure of the medicinal solution inside.
[0049] The configurations of the replacement pipeline section 10 and the control device 40 are the same as those in the first embodiment. The configuration of the common pipeline section 30 is almost the same as that in the first embodiment, but differs from the first embodiment in that the first liquid medicine bag 34 is not connected to the pipeline of the first liquid medicine line 31, and the second liquid medicine bag 36 is not connected to the pipeline of the second liquid medicine line 32. The rest is the same as the first embodiment, including the presence of the first liquid medicine line 31 through which a contrast medium flows as the first liquid medicine and the second liquid medicine line 32 through which physiological saline flows as the second liquid medicine.
[0050] An opening 71a in the first container 71 is fluidly connected to the first liquid medicine line 31, and an opening 72a in the second container 72 is fluidly connected to the second liquid medicine line 32. The control for the operation of the first pressurizing body 73 and the second pressurizing body 74 by the control device 40 is the same as in the first embodiment. That is, the first pressurizing body 73 and the second pressurizing body 74, which receive commands from the control device 40, pressurize the first container 71 and the second container 72 in a predetermined sequence. Here, the central processing unit 41 of the control device 40 determines the pressure in the liquid medicine injection pipeline from the electric signals (electric signals corresponding to the amount of power or current input to each pressurizing pump) input to the first pressurizing body 73 and the second pressurizing body 74 when driving the first pressurizing body 73 and the second pressurizing body 74, as shown in FIG. 3A, in the same manner as in the first embodiment. When the electric signal input to the first pressurizing body 73 and the second pressurizing body 74 indicates that the pressure in the drug solution injection pipeline has reached a value corresponding to a predetermined pressure (Psafe) (time T1 has elapsed), the pressure in the common pipeline section 30 becomes higher than that in the replacement pipeline section 10. Then, the control device 40 sends a command to the driving means 6 to open the flow cutoff unit 5, which is in the closed state. In this state, the subject's body fluid does not flow back upstream of the flow cutoff unit 5, that is, at least to the most downstream of the common pipeline section 30.
[0051] The reverse is also true. That is, when the respective medicinal liquids in the first container 71 or the second container 72 run out, the pressure in the medicinal liquid injection pipeline including the first container 71 or the second container 72 starts to drop (at the time T3 has elapsed). When it is determined from the electric signal transmitted to the first pressurizing body 73 and the second pressurizing body 74 that the pressure in the medicinal liquid injection pipeline has reached a predetermined pressure (Psafe) (at the time T4 has elapsed), the control device 40 sends a command to the driving means 6 to close the flow interruption unit 5, which is in the open state. At this stage, the pressure in the common pipeline section 30 becomes higher than the replacement pipeline section 10 side. In this state, the subject's body fluids do not flow back to the common pipeline section 30. The common pipeline section 30 can be removed from the replacement pipeline section 10 in this state. As a result, in the third embodiment as well, it is possible to create a timing at which the pressure in the common pipeline section 30 becomes higher than the replacement pipeline section 10 side, as in the first embodiment.
[0052] As a modification of the third embodiment, the first pressurizing body 73 and the second pressurizing body 74 may each be a pressurizing winding body 75 as shown in FIG. 7B. That is, in the modification of the third embodiment, the first container 71 and the second container 72 are typically flexible bag-shaped containers, typically resin bags, but the material is not important. The liquid medicine supplying means of the liquid medicine injector 20 is a pressurizing winding body 75 that pressurizes the first container 71 and the second container 72, as shown in FIG. 7A. The pressurizing winding body 75 advances in the direction of the opening 71a and the opening 72a while rolling up the flexible first container 71 and the second container 72, crushing the first container 71 and the second container 72. The control circuit 27 is the same as that of the first embodiment, and the pressurizing winding body 75 is controlled by the control circuit 27. The pressure of the liquid medicine in the first container 71 and the second container 72 is increased from the outside of the first container 71 and the second container 72 by the pressure winder 75, and the first liquid medicine in the first container 71 and the second liquid medicine in the second container 72 are caused to flow. Then, when the electric signal input from the control device 40 to the pressure winder 75 indicates that the pressure in the liquid medicine injection line has reached a value corresponding to a predetermined pressure (Psafe) (time T1 has elapsed), the pressure in the common pipe line section 30 becomes higher than that of the replacement pipe line section 10. Then, the control device 40 sends a command to the drive means 6 to open the flow blocking unit 5, which is in the closed state. In this state, the subject's body fluid does not flow back to the common pipe line section 30. Furthermore, when it is determined from the electrical signal input to the pressure winder 75 that the pressure in the drug solution injection pipeline has reached a predetermined pressure (Psafe) (when time T4 has elapsed), the control device 40 sends a command to the drive means 6 to close the flow blocking unit 5, which is in the open state. At this stage, the pressure in the common pipeline section 30 becomes higher than the replacement pipeline section 10 side. In this state, the subject's body fluids do not flow back to the common pipeline section 30. The common pipeline section 30 can be removed from the replacement pipeline section 10 in this state. As a result, in the third embodiment as well, it is possible to create a timing at which the pressure in the common pipeline section 30 becomes higher than the replacement pipeline section 10 side, as in the first embodiment.
[0053] (Fourth Example) Next, the fourth embodiment will be described with reference to Figs. 8 and 9. The fourth embodiment is a type of embodiment in which the downstream pipe is depressurized to pump the liquid medicine. Fig. 8 shows an overall configuration diagram of a liquid medicine injector 1d of the fourth embodiment. The liquid medicine injector 1d is the same as the first embodiment in that it includes a replacement pipe section 10, a liquid medicine injector 20, a common pipe section 30, and a control device 40, and is also configured so that the liquid medicine supplied from the liquid medicine injector 20 first flows into the common pipe section 30, which is a liquid medicine injection pipe, and then flows from the common pipe section 30 to the replacement pipe section 10. In the fourth embodiment, the replacement pipe section 10 and the common pipe section 30 form a liquid medicine injection pipe, and the replacement pipe section 10 is replaced for each subject, while the common pipe section 30 is used in common for multiple subjects. Below, the fourth embodiment will be described in terms of differences from the third embodiment. In the liquid injector 1d of the fourth embodiment, a roller pump 83 and a roller pump 84 are used as the liquid supplying means. Other than that, the configuration of the third embodiment can be applied as it is.
[0054] The liquid injector 20 includes a liquid supply source and a pump. The liquid source of the liquid injector 20 is a first container 81 for supplying a contrast medium as a first liquid, and a second container 82 for supplying physiological saline as a second liquid. As the pump, any type of pump can be applied as long as it has a structure in which the liquid in the upstream pipe is pressure-reduced while pressing the downstream pipe, and the liquid in the upstream pipe is pressure-fed to the downstream pipe. Typical examples of this type of pump are roller pumps and finger pumps. Here, roller pump 83 and roller pump 84 are described as examples. Each of the first container 81 and the second container 82 may be a hard resin container or a flexible bag-shaped resin container. The material is not important. The roller pump 83 and the roller pump 84 are respectively disposed in the pipeline of the first chemical liquid line 31 joined to the opening 81a of the first container 81 of the common pipeline section 30, and in the pipeline of the second chemical liquid line 32 joined to the opening 82a of the second container 82. The roller pump 83 and the roller pump 84 may be attached anywhere in the pipeline of the chemical liquid in the common pipeline section 30, as long as it is upstream of the flow blocking unit 5. They may also be attached to the mixing supply tube 18. The pipeline of the first chemical liquid line 31 and the pipeline of the second chemical liquid line 32 in which the roller pump 83 and the roller pump 84 are disposed are made of soft tubes, and the pipeline of the first chemical liquid line 31 and the pipeline of the second chemical liquid line 32 are fixed and disposed so as to be wound around the rotor 85.
[0055] The roller pump 83 and the roller pump 84 will be described with reference to FIG. 9. FIG. 9 is an enlarged functional configuration diagram of the roller pump 83. The roller pump 84 has the same configuration, so the roller pump 83 will be described instead of the roller pump 84. The roller pump 83 has a rotor 85. The rotor 85 can rotate around the center of rotation of the rotor. On a circumference centered on the center of rotation of the rotor 85, at least two protrusions, namely, a pressing portion 85a and a pressing portion 85b, are provided so that the arc distance is equally spaced. That is, the two pressing portions 85a and 85b are arranged at a central angle of 180 degrees on a circumference centered on the center of rotation of the rotor 85. For example, when three pressing portions are arranged, they are arranged at a central angle of 120 degrees, and when four pressing portions are arranged, they are arranged at a central angle of 90 degrees.
[0056] The pressing parts 85a and 85b of the two protrusions respectively crush the pipeline of the first chemical liquid line 31. At the places where the pressing parts 85a and 85b crush the pipeline of the first chemical liquid line 31, the pipeline of the first chemical liquid line 31 is narrowed, and a section 31b into which the chemical liquid can enter is formed between the pressing parts 85a and 85b. On both sides of the section 31b, an upstream section 31a and a downstream section 31c are formed. In this state, for example, when the rotating body 85 is rotated clockwise in FIG. 9 (in the direction of the arrow in FIG. 9), the pressing part 85a moves on the section 31b while pressing the pipeline of the first chemical liquid line 31. When the pressing parts 85a and 85b move by a central angle 180 of the rotation center of the rotating body 85, the positions of the pressing parts 85a and 85b are reversed. During this movement, the pressure at the location where pressing portion 85a is constricted is reduced compared to compartments 31a and 31c on both ends, so the pressure in compartment 31b is lower than that of compartment 31a on the upstream side, and when pressing portion 85b reaches the location where pressing portion 85a was located, the liquid medicine in compartment 31a on the upstream side flows into compartment 31b, and the liquid medicine enters compartment 31b between pressing portion 85a and pressing portion 85b. When rotating body 85 further in this state, pressing portion 85b moves over compartment 31b while pressing the pipeline of first liquid medicine line 31 so as to pump the liquid medicine in the pipeline of first liquid medicine line 31, and the liquid medicine moves to downstream compartment 31c. In this manner, by continuously rotating the rotor 85, the medicinal liquids in the first container 81 and the second container 82 are supplied to the pipeline of the first medicinal liquid line 31 and the second medicinal liquid line 32, and are then supplied from the common pipeline section 30 to the replacement pipeline section 10. The rest is the same as in the first embodiment, including the presence of the first medicinal liquid line 31 through which the contrast medium flows as the first medicinal liquid, and the second medicinal liquid line 32 through which physiological saline flows as the second medicinal liquid.
[0057] The control of the roller pump 83 and the roller pump 84 by the control device 40 is the same as that in the first embodiment. That is, the roller pump 83 and the roller pump 84, which receive a command from the control device 40, reduce the pressure in the pipeline corresponding to the section 31b between the pressing portion 85a and the pressing portion 85b of the pipeline of the first chemical liquid line 31 and the second chemical liquid line 32 in a predetermined sequence. Here, the central processing unit 41 of the control device 40 determines the pressure in the chemical liquid injection pipeline from the electric signal (electric signal corresponding to the amount of power or current input to the roller pump 83 and the roller pump 84) input to the roller pump 83 and the roller pump 84 when driving the roller pump 83 and the roller pump 84, as in the first embodiment, as shown in FIG. 3A. At the stage (time T1 lapse stage) when the electric signal input to the roller pump 83 and the roller pump 84 indicates that the pressure in the chemical liquid injection pipeline has reached a value corresponding to a predetermined pressure (Psafe), the pressure in the common pipeline section 30 becomes higher than that of the replacement pipeline section 10. Therefore, the control device 40 sends a command to the driving means 6 to open the flow cutoff unit 5 from the closed state. In this state, the subject's body fluid does not flow back upstream of the flow cutoff unit 5, that is, at least to the most downstream of the common conduit portion 30.
[0058] The reverse is also true. That is, when the respective medicinal liquids in the first container 81 or the second container 82 run out, the pressure in the medicinal liquid injection pipeline including the first container 81 or the second container 82 starts to drop (at the time T3 has elapsed). When it is determined from the electric signal transmitted to the roller pump 83 and the roller pump 84 that the pressure in the medicinal liquid injection pipeline has reached a predetermined pressure (Psafe) (at the time T4 has elapsed), the control device 40 sends a command to the driving means 6 to close the flow interruption unit 5, which is in the open state. At this stage, the pressure in the common pipeline section 30 becomes higher than the replacement pipeline section 10 side. In this state, the subject's body fluids do not flow back to the common pipeline section 30. The common pipeline section 30 can be removed from the replacement pipeline section 10 in this state. As a result, in the third embodiment as well, it is possible to create a timing at which the pressure in the common pipeline section 30 becomes higher than the replacement pipeline section 10 side, as in the first embodiment.
[0059] (Other embodiments) Next, another embodiment of the present invention will be described. The embodiment described here has the same configuration as the liquid medicine injector 1a of the first embodiment of the present invention described above. In this embodiment, in the flowchart of FIG. 3B, the predetermined amount of liquid medicine has not yet been injected, but the sequence is performed after the pressure in the liquid medicine injecting pipeline reaches a predetermined pressure (Psafe) (at the time when time T4 has elapsed) before the injection of the liquid medicine is completed, and the flow blocking unit 5 is in a closed state. That is, since the predetermined amount of liquid medicine has not yet been injected, the sequence is to refill the first syringe 21 with the first liquid medicine and the second syringe 22 with the second liquid medicine. This embodiment will be described with reference to FIG. 10. Here, the description will be made by referring directly to the configuration of the device of the first embodiment of the present invention described above. FIG. 10 shows a flowchart of the sequence of refilling the first syringe 21 or the second syringe 22 with the liquid medicine.
[0060] Since the pressure in the liquid medicine injection line has decreased to a predetermined pressure (Psafe), the control device 40 is instructed to close the flow cutoff unit 5, and the flow cutoff unit 5 is in the closed state (S7 in FIG. 3B). This embodiment proceeds from this step. First, it is confirmed that the flow cutoff unit 5 is in the closed state, and the flow cutoff unit 5 is maintained in the closed state (S11). Next, the first liquid medicine valve 34a is opened to communicate the first liquid medicine bag 34 with the first liquid medicine line 31, and the second liquid medicine valve 36a is opened to communicate the second liquid medicine bag 36 with the second liquid medicine line 32 (S12). If the first liquid medicine valve 34a and the second liquid medicine valve 36a are one-way valves rather than open / close valves, the process of opening the first liquid medicine valve 34a and the second liquid medicine valve 36a (S12) is not necessary. Since the blocking unit 5 is closed, a pressure gradient is created in each of the first chemical liquid line 31 and the second chemical liquid line 32, which allows the first chemical liquid bag 34 to flow toward the first syringe 21 via the first chemical liquid line 31 and the second chemical liquid bag 36 to flow toward the second syringe 22 via the second chemical liquid line 32. In this state, a command is issued from the central processing unit (CPU) 41 of the control device 40 to the first motor 23 and the second motor 24 to rotate in the reverse direction. Having received the command, the first motor 23 and the second motor 24 retract the piston 21c of the first syringe 21 or the piston 22c of the second syringe 22 in a predetermined sequence.
[0061] As a result, the pressure in the drug solution injection pipeline including first syringe 21 or second syringe 22 gradually decreases, and the first drug solution is sucked from first drug solution line 31 into first syringe 21, and the second drug solution is sucked into second syringe 22 of second drug solution line 32 (S13). It is determined whether a predetermined amount of the first drug solution has been filled into first syringe 21 and a predetermined amount of the second drug solution has been filled into second syringe 22, and if not yet filled, the filling continues, and if the predetermined amounts of the first drug solution have been filled into first syringe 21 and the second drug solution have been filled into second syringe 22, the filling is completed (S14). If a predetermined amount of the first chemical liquid has been filled in first syringe 21 and a predetermined amount of the second chemical liquid has been filled in second syringe 22, at the stage where filling is completed, first chemical liquid valve 34a is closed to isolate first chemical liquid bag 34 from first chemical liquid line 31, and second chemical liquid valve 36a is closed to isolate second chemical liquid bag 36 from second chemical liquid line 32 (S15). If first chemical liquid valve 34a and second chemical liquid valve 36a are one-way valves rather than open / close valves, the process of closing first chemical liquid valve 34a and second chemical liquid valve 36a (S15) is not necessary. At this time, since the first syringe 21 or the second syringe 22 is performing suction, the pressure in the conduit of the common conduit section 30 may become locally (for example, at a location D2 in FIG. 1) lower than the intravascular pressure of the subject, and the subject's bodily fluid may flow back to the common conduit section 30. Therefore, when a predetermined amount of the first medicinal liquid is filled in the first syringe 21 and the second medicinal liquid is filled in the second syringe 22, and the filling is completed, it is necessary to pressurize the inside of the conduit of the common conduit section 30 to a predetermined pressure (Psafe) higher than the intravascular pressure of the subject. Therefore, a command is issued from the central processing unit (CPU) 41 of the control device 40 to the first motor 23 and the second motor 24 to rotate forward. Upon receiving the command, the first motor 23 and the second motor 24 advance the piston 21c of the first syringe 21 or the piston 22c of the second syringe 22 in a predetermined sequence, and pressurize the pressure to a predetermined pressure (Psafe) higher than the intravascular pressure of the subject (S16).When pressurizing to a predetermined pressure (Psafe) higher than the intravascular pressure of the subject, the pressure in the drug solution injection pipeline may be measured as in the case of the timing when the control device 40 in the first embodiment sends a command to open the flow blocking unit 5 to allow the flow of drug solution (S3) and to close the flow blocking unit 5 to block the flow of drug solution (S7), or a method that does not directly measure the pressure in the drug solution injection pipeline may be adopted. At this stage, the pressure in the common pipeline section 30 becomes higher than the replacement pipeline section 10 side, and the subject's body fluid does not flow back to the common pipeline section 30. From this point, it is possible to resume the sequence from S1 in FIG. 3B.
[0062] This application claims priority from Japanese Patent Application No. 2018-124918, filed on June 29, 2018, the entire contents of which are incorporated herein by reference. [Explanation of symbols]
[0063] 1a, 1b, 1c, 1d Chemical injection device 5 Flow Blocking Unit 6. Driving Means 10 Replacement Pipe Section 11 Piercing member 12 Injection tube 15 Mixing Devices 18 Mixing supply tube 20. Chemical Injector 23,24 Drive motor 25,26 Pressing member 27 Control circuit 28,29 Load cells 30 Common pipe section 40 Control device 41 Central Processing Unit 61,71 1st container 62,72 2nd container 73 First pressure body 74 Second pressure body 83,84 Roller pump 85 Rotating Body
Claims
1. A drug solution injector for injecting a drug solution into a subject, a liquid injector including a liquid source having an opening and a liquid supply means for discharging the liquid from the opening; A control device for controlling the driving of the chemical solution supplying means; a flow blocking unit that can be switched between an open state in which the drug solution is permitted to flow and a closed state in which the drug solution is blocked by receiving a command from the control device; The control device is a drug solution injection device that sends a command to the flow cut-off unit to change the flow cut-off unit to the open state allowing the flow of the drug solution when a predetermined time has elapsed after the drug solution has started to be supplied from the drug solution injector.
2. A drug solution injector for injecting a drug solution into a subject, a liquid injector including a liquid source having an opening and a liquid supply means for discharging the liquid from the opening; A control device for controlling the driving of the chemical solution supplying means; a flow blocking unit that can be switched between an open state that allows the flow of the chemical solution and a closed state that blocks the flow of the chemical solution by receiving a command from the control device; a tube to which the flow interrupter unit is attached; the drug solution injector is provided upstream of the flow cutoff unit so as to pressurize the drug solution and increase the pressure in the tube upstream of the flow cutoff unit; The control device is a liquid medicine injection device that sends the command to the flow cut-off unit to close the flow of the liquid medicine when a predetermined time has elapsed after the liquid medicine has been supplied from the liquid medicine injector.
3. The drug solution injector according to claim 1, A liquid medicine injection device, wherein the predetermined time is a time during which a predetermined pressure is applied so that the pressure upstream of the flow cut-off unit is high while the flow cut-off unit is in a closed state to cut off the flow of the liquid medicine.
4. The chemical liquid injector according to claim 2, The specified time is a chemical solution injection device that is set such that the supply of chemical solution from the chemical solution injector is completed simultaneously or a certain period of time during which a high pressure state is ensured upstream of the flow blocking unit with the flow blocking unit in a closed state that blocks the flow of the chemical solution.
5. The liquid injector according to claim 1 or 2, A replacement pipe section that supplies the drug solution to the blood vessel of the subject; a common conduit section connected to the opening of the liquid medicine source for allowing the liquid medicine to flow from the liquid medicine injector to the replacement conduit section; The flow interrupting unit is disposed in the replacement pipeline section or in a pipeline at a boundary between the replacement pipeline section and the common pipeline section.
6. The liquid injector according to claim 1 or 2, A replacement pipe section that supplies the drug solution to the blood vessel of the subject; a common conduit section connected to the opening of the liquid medicine source for allowing the liquid medicine to flow from the liquid medicine injector to the replacement conduit section; The flow interrupting unit is a chemical liquid injection device having a closed state in which the flow of the chemical liquid is interrupted by a member that sandwiches a pipe that constitutes the replacement pipeline section or a pipe that constitutes the common pipeline section.
7. The liquid injector according to claim 1 or 2, The flow shutoff unit is a shutoff valve.
8. The liquid injector according to any one of claims 1 to 7, The liquid medicine source of the liquid medicine injector is a syringe including an outer cylinder and a piston that is inserted into the outer cylinder and moves relative to the outer cylinder to press the liquid medicine so as to push the liquid medicine out of the opening, The liquid injector includes a drive motor that applies a pressing force to the piston for discharging the liquid.
9. The drug solution injector according to claim 1, The predetermined time is preset so that the pressure in the tube to which the flow blocking unit is attached increases to a predetermined pressure.
10. The chemical liquid injector according to claim 2, The predetermined time is preset within a time range in which the pressure inside the tube is maintained at or above a predetermined pressure.
Citation Information
Patent Citations
Fluid transport device and method for driving the fluid transport device
JP2011167272A
Liquid medicine injection apparatus
JP2004065736A
Chemical liquid circuit and chemical liquid system using same
WO2014104338A1
